Abstract
Skin function is not limited to a physical barrier. According to its total surface area, it is also considered as an extra-hepatic metabolizing organ. In vitro engineered human skins have been developed to replace limited ex vivo normal human skin samples (NHS). Thus, assessing and comparing skin models from SkinEthic [Episkin™, RHE™ and the full thickness model (FTM)] with NHS in terms of metabolic capability are essential. The apparent activities of main cutaneous isoforms of cytochrome P450-dependent monooxygenases (CYP1A1/1B1, 2B6/2C18/2E1, 3A5/3A7), esterase, glutathione-S-[(GST), A, M, P, T], N-acetyl-(NAT1), uridinyl-diphosphate glucuronyl-(UDPGT 1A family) and sulfo-(SULT1A1) transferases were determined using probe substrates. Mean activities indicative of CYP1A1/1B1 (expressed as pmol/mg protein/6 h) in RHE™ (2.8) and FTM (2.6) were very similar to NHS (3.0) while Episkin™ showed a higher activity (9.1). Activities of CYP3A5/3A7 in FTM (3.3) and Episkin™ (3.6) were similar to NHS (3.8) while activity in RHE™ (13.3) was higher. CYP2B6/2C18/2E1 activity was below LOQ (0.5) in all skin models and NHS. Comparable intrinsic metabolic clearances were measured between NHS and skin models for esterase, UDPGT, GST and NAT1 activities. SULT1A1 activity toward probe substrates was not detected in skin models and observed at the limit of detection in NHS. Weak cytochrome P450-dependent monooxygenases, high esterase and transferase activities suggested that NHS and skin models exhibited limited functionalization and much greater detoxification (hydrolytic and conjugating) capacities. These results demonstrate that skin models are similar to NHS in terms of metabolic functionality toward xenobiotics investigated and useful tools to assess both the local efficiency and safety of cosmetics.
Similar content being viewed by others
Abbreviations
- BSA:
-
Bovine serum albumin
- CDNB:
-
Chloro-2,4-dinitrobenzene
- CYP:
-
Cytochrome P450-dependent monooxygenases
- DNPSG:
-
Dinitrophenyl S-glutathione conjugate
- EROD:
-
7-ethoxy resorufin O-deethylase
- ES:
-
Esterases
- FTM:
-
Full thickness model of SkinEthic
- GST:
-
Glutathione-S transferases
- HPLC:
-
High-performance liquid chromatography
- LOD:
-
Limit of detection
- LOQ:
-
Limit of quantification
- MTT:
-
1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenyltetrazolium bromide
- NAT:
-
N-acetyl transferases
- α-NF:
-
α-Naphthoflavone
- NHS:
-
Normal human skin
- PABA:
-
para-Aminobenzoic acid
- PAcBA:
-
para-Acetamidobenzoic acid
- PNP:
-
para-Nitrophenol
- PNPS:
-
para-Nitrophenyl sulfate
- RT-PCR:
-
Real-time polymerase chain reaction
- SDS:
-
Sodium dodecyl sulfate
- S.E.M:
-
Standard error of the mean
- SPE:
-
Solid-phase extraction
- SULT:
-
Sulfo-transferases
- TCA:
-
Trichloroacetic acid
- TFA:
-
Trifluoroacetic acid
- UDPGT:
-
Uridyl diphosphate glucuronyl transferases
- 4-MU:
-
4-Methylumbelliferone
- 4-MUAc:
-
4-Methylumbelliferyl acetate
- 4-MUG:
-
4-Methylumbelliferyl-β-glucuronide
- 7-BFCOD:
-
7-Benzyloxy-4-(trifluoromethyl)-coumarin O-debenzylation
- 7-BFC:
-
7-Benzyloxy-4-(trifluoromethyl)-coumarin
- 7-ER:
-
7-Ethoxyresorufin
- 7-HFC:
-
7-Hydroxy-4-(trifluoromethyl)-coumarin
- 7-MFCOD:
-
7-Methoxy-4-(trifluoromethyl)-coumarin O-demethylase
- 7-MFC:
-
7-Methoxy-4-(trifluoromethyl)-coumarin
References
Bourrié M, Meunier V, Berger Y, Fabre G (1996) Cytochrome P450 isoform inhibitors as tool for the investigation of metabolic reaction catalyzed by human liver microsomes. J Pharm Exp Therap 277(1):321–332
Bursztyka J, Debrauwer L, Perdu E, Jouanin I, Jaeg JP, Cravedi JP (2008) Biotransformation of vinclozolin in rat precision-cut liver slices: comparison with in vivo metabolic pattern. J Agric Food Chem 56(12):4832–4839
Chung-sang H, Hsiu-Maan K, Chun-Su Y, Te-Mao L (2004) Evidence for arylamine N-acetyltransferase activity in Klebsiella pneumoniae. J Microbiol Immunol Infect 37(4):208–215
Cotovio J, Roguet R, Pion FX, Rougier A, Leclaire J (1996) Effect of imidazole derivatives on cytochrome P-450 enzyme activities in a reconstructed human epidermis. Skin Pharmacol 9(4):242–249
Ekins S, Murray GI, Burke MD, Williams JA, Marchant NC, Hawksworth GM (1995) Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug Metab Dispos 23(11):1274–1279
Gibbs S, Van de Sandt JJM, Merk HF, Lockley DJ, Pendlington RU, Pease CK (2007) Xenobiotic metabolism in human skin and 3d human skin reconstructs. Rev Curr Drug Metab 8(8):1–15. doi:10.2174/138920007782798225
Götz C, Pfeiffer R, Tigges J, Blatz V, Jäckh C, Freytag EM, Fabian F, Landsiedel R, Merk HF, Krutmann J, Edwards RJ, Pease C, Goebel C, Hewitt N, Fritsche E (2012) Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I). Exp Dermatol 21:358–363. doi:10.1111/j.1600-0625.2012.01486
Harris IR, Siefken W, Beck-Oldach K, Brandt M, Wittern KP, Pollet D (2002) Comparison of activities dependent on glutathione s-transferase and cytochrome P-450 Ia1 in cultured keratinocytes and reconstructed epidermal models. Skin Pharmacol Appl 15(suppl1):59–67
He D, Falany CN (2006) Characterization of proline-serine-rich carboxyl terminus in human sulfotransferase 2B1b: immunogenicity, subcellular localization, kinetic properties, and phosphorylation. Drug Metab Dispos 34(10):1749–1755. doi:10.1124/dmd.106.011114
Hewitt NJ, Edwards RJ, Fritsche E, Goebel C, Aeby P, Scheel J, Reisinger K, Ouédraogo G, Duche D, Eilstein J, Latil A, Kenny J, Moore C, Kuehnl J, Barroso J, Fautz R, Pfuhler S (2013) Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations. Toxicol Sci 133(2):209–217. doi:10.1093/toxsci/kft080
Hu T, Khambatta ZS, Hayden PJ, Bolmarcich J, Binder RL, Robinson MK, Carr GJ, Tiesmann JP, Jarrold BB, Osborne R, Reichling TD, Nemeth ST, Aardema MJ (2010) Xenobiotic metabolism gene expression in the Epiderm™ in vitro 3D human epidermis model compared to human skin. Toxicol In Vitro 24(5):1450–1463. doi:10.1016/j.tiv2010.03.013
Jewell C, Ackermann C, Payne NA, Fate G, Voorman R, Williams F (2007) Specificity of procaine and ester hydrolysis by human, minipig, and rat skin and liver. Drug Metab Dispos 35(11):2015–2022. doi:10.1124/dmd.107.015727
Katiyar SK, Matsui MS, Mukhtar H (2000) Ultraviolet-B exposure of human skin Induces cytochromes P450 1A1 and 1B1. J Invest Dermatol 114(2):328–333
Kondo H, Moriuchi F, Sunamoto J (1981) S & → N and N & → S Reverse rearrangement of S- and N-(2.4-dinitrophenyl)cysteines. J Org Chem 46:1333–1336
Kürschner U (2007) Untersuchungen zur Toxizität und Biotransformation an der humanen Keratinozytenzelllinie HaCaT. PhD Thesis, der Martin- Luther- Universität Halle- Wittenberg
Lokeshwar VB, Lopez LE, Munoz D, Chi A, Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N, Altman N (2010) Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res 70(7):2613–2623. doi:10.1158/0008-5472
Luu-The V, Ferraris C, Duche D, Leclaire J, Labrie F (2007) Steroid metabolism and profile of steroidogenic gene expression in EpiskinTM: high similarity with human epidermis. J Steroid Biochem Mol Biol 107(1–2):30–36. doi:10.1016/j.jsbmb.2007.03.036
Luu-The V, Duche D, Ferraris C, Meunier JR, Leclaire J, Labrie F (2009) Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models EpiskinTM and full thickness model from EpiskinTM. J Steroid Biochem Mol Biol 116(3–5):178–186
McNeilly AD, Woods JA, Ibbotson SH, Roland Wolf C, Smith G (2012) Characterization of a human keratinocyte HaCaT cell line model to study the regulation of CYP2S1. Drug Metab Dispos 40(2):283–289. doi:10.1124/dmd.111.042085
Merk HF (1997) Chapter 5—skin metabolism. In: Lepoittevin JP, Basketter DA, Goosens A, Karlberg AT (eds) Allergic contact dermatitis. Springer, London, pp 68–80
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63
Oesch F, Fabian E, Oesch-Bartlomowicz B, Werner C, Landsiedel R (2007) Drug-metabolizing enzymes in the skin of man, rat, and pig. Drug Metab Rev 39(4):659–698. doi:10.1080/03602530701690366
Park HJ, Cho HY, Kong KH (2005) Purification and biochemical properties of glutathione S-transferase from Lactuca sativa. J Biochem Mol Biol 38(2):232–237
Sànchez-Gòmez FJ, Gayarre J, Avellano MI, Pérez-Sala D (2007) Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implication for enzyme inactivation and cell survival. Arch Biochem Biophys 457(2):150–159
Scientific committee on consumer products opinion on 4-aminobenzoic acid (PABA). http://ec.europa.eu/health/ph_risk/committees/04_sccp/docs/sccp_o_058.pdf (Accessed 2006)
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Analyt Biochem 150(1):76–85
Stresser MD, Blachard PA, Turner SD, Erve JCL, Dandeneau AA, Miller VP, Crespi CL (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28(12):1440–1448
Svensson CK (2009) Minireview biotransformation of drug in human skin. Drug Metab Dispos 37(2):247–253. doi:10.1124/dmd.108.024794
Tang SS, Chang GG (1996) Kinetic mechanism of octopus hepatopancreatic glutathione transferase in reverse micelles. Biochem J 315(2):599–606
Testa B, Krämer D (2008) In: Kisakürek MV, Kolitzus T (eds) The biochemistry of drug metabolism: principle, redox reaction, hydrolyses. Verlag Helvetica Chimica Acta, Zürich
Tinois E, Tiollier J, Gaucherand M, Dumas H, Tardy M, Thivolet J (1991) In vitro and post-transplantation differentiation of human keratinocytes grown on the human type IV collagen film of a bilayered dermal substitute. Exp Cell Res 193(2):310–319
Tobin DJ (2006) Biochemistry of human skin-our brain of the outside. Chem Soc Rev 35(1):52–67
Uchaipichat V, Mackenzie PI, Guo XH, Gardner-Stephen D, Galetin A, Houston JB, Miners J (2004) Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab Dispos 32(4):413–423. doi:10.1124/dmd.32.4.413
Vaidya SS, Gerk PM (2007) Simultaneous determination of 1-chloro-2.4-dinitrobenzene, 2.4-dinitrophenyl-S-glutathione and its metabolites for human placental disposition studies by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 859:94–102
Van Eijl S, Zhu Z, Cupitt J, Gierula M, Götz C, Fritsche E, Edwards RJ (2012) Elucidation of xenobiotic metabolism pathways in human skin and human skin models by proteomic profiling. PLoS ONE 7(7):e41721. doi:10.1371/journal.pone.0041721
Walkera K, Ginsbergb G, Hattisa D, Johnsc DO, Guytonc KZ, Sonawanec B (2009) Genetic polymorphism in N-Acetyltransferase (NAT): population distribution of NAT1 and NAT2 activity. J Toxicol Environ Health B Crit Rev 12(5–6):440–472. doi:10.1080/10937400903158383
Wang W, Ballatori N (1998) Endogenous glutathione conjugates: occurrence and biological functions. Pharma Rev 50(3):335–355
Zalko D, Perdu-Durand E, Debrauwer L, Bec-Ferte MP, Tulliez J (1998) Comparative metabolism of clenbuterol by rat and bovine liver microsomes and slices. Drug Metab Dispos 26(1):28–35
Acknowledgments
We wish to thank Pr. Daniel Mansuy (UMR 8601, Paris Descartes University, France), Dr. Marcel Delaforge (URA 2096, CEA Saclay, Gif-sur-Yvette), Pr Van Luu-The (Oncology, Molecular Endocrinology and Genomic Research Center, Quebec University Hospital Research Center and Laval University, Quebec, CANADA) and Dr Bruno A. Bernard (L’Oréal Research and Innovation, France) for their advice and scientific assistance. We would also like to thank Oroxcell SA for its technical assistance in P450-dependent monooxygenase experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eilstein, J., Léreaux, G., Budimir, N. et al. Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic. Arch Toxicol 88, 1681–1694 (2014). https://doi.org/10.1007/s00204-014-1218-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-014-1218-6